Bradley Champagne, MD
Colon & Rectal Surgery · Cleveland, OHNPI 1154357085
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,800 of the $7,879 with a category attached, or 60.9%. Covidien LP accounts for 61.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $5,303 and has fallen 86.6% since, to $710 in 2025.
Across 34 payments — averaging $231.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$5K
- Intuitive Surgical$957
- Medtronic$598
- Innovation Technologies Inc$380
- Conmed Corporation$374
- Dilon Technologies, Inc.$159
- plus $533 from 6 others
What the payments were for
- Speaking & faculty fees$4,80061%
- Travel & lodging$2433%
- Food & beverage$2,80236%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 6 | $4,878 |
| Intuitive Surgical | 4 | $957 |
| Medtronic(2 entities) | 7 | $598 |
| Innovation Technologies Inc | 3 | $380 |
| Conmed Corporation | 5 | $374 |
| Dilon Technologies, Inc. | 1 | $159 |
| Johnson & Johnson | 2 | $150 |
| Prescient Surgical | 1 | $134 |
| Pacira Pharmaceuticals Incorporated | 1 | $121 |
| Guard Medical Inc. | 1 | $91 |
| Merck | 2 | $23 |
| Axonics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sonicision$3,200
- LigaSure$1,727
- Da Vinci Surgical System$903
- Irrisept$322
- AIRSEAL$242
- Signia$170
- HemoBlast Bellows$159
- CONMED GENERATORS$141
- CleanCision$134
- SURGICEL NU-KNIT$123
- EXPAREL$121
How this compares
$7,879 in reported general payments places this provider in the 80th percentile of 101 colon & rectal surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 16 | $80 |
| Metronidazole | 18 | $21 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Cleveland
- Vincent ObiasCleveland$124K
- David RosenCleveland$102K
- Jean AshburnCleveland$81K
- Anna SpivakCleveland$54K
- Scott SteeleCleveland$28K
- Michael LiuCleveland$18K
- Conor DelaneyCleveland$16K
- Stefan HolubarCleveland$12K
- David DietzCleveland$11K
- Haniee ChungCleveland$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.